Mitotane-13C6

CAT: 0804-HY-13690S1Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-13690S1Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Mitotane-13C6 is the 13C labeled Mitotane[1]. Mitotane (2,4′-DDD), an isomer of DDD and derivative of dichlorodiphenyltrichloroethane (DDT), is an antineoplastic agent, can be used to research adrenocortical carcinoma. Mitotane exert its adrenocorticolytic effect at least in part through lipotoxicity induced by intracellular free cholesterol (FC) accumulation. Mitotane can have direct pituitary effects on corticotroph cells. Mitotane can induce CYP3A4 gene expression via steroid and xenobiotic receptor (SXR) activation, and has agent-agent interactions[2][3][4][5].
CAS Number
[1261396-21-7]
Product Name Alternative
2,4′-DDD-13C6; o, p'-DDD-13C6
UNSPSC
12352005
Target
Apoptosis
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mitotane-13c6.html
Purity
98.62
Solubility
10 mM in DMSO
Smiles
ClC(Cl)C([13C]1=[13CH][13CH]=[13C]([13CH]=[13CH]1)Cl)C2=C(C=CC=C2)Cl
Molecular Formula
C8 13C6H10Cl4
Molecular Weight
326.00
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Takeshita A, Igarashi-Migitaka J, Koibuchi N, Mitotane induces CYP3A4 expression via activation of the steroid and xenobiotic receptor. J Endocrinol. 2013 Feb 15;216 (3) :297-305.|[3]Doghman M, et al. Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma. Mol Cell Endocrinol. 2013 Dec 5;381 (1-2) :66-9.|[4]Zatelli MC, et al. Therapeutic concentrations of mitotane (o, p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology. 2010 Jun;151 (6) :2453-61.|[5]Warde KM, et al. Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma. Endocrinology. 2022 Sep 1;163 (9) :bqac102.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-13690-01Mitotane
HY-13690S3Mitotane-13C12
HY-13690R-01Mitotane (Standard)
HY-13690S2Mitotane-d8
HY-10572S1-01Efavirenz-13C6
HY-W585956Triclocarban-13C6
HY-17356S2Fenofibrate-13C6
HY-W777526Nitisinone-13C6
HY-B0174ASOlsalazine-13C6
HY-B0141S4Estradiol-13C6

Alternative Products

CatalogName
164988Mitotane-13C6
TRC-M372500-50MGMitotane
A10594-500Mitotane 500mg
A10594-50Mitotane 50mg
A10594-100Mitotane 100mg
TRC-H278355-100MGHydroxy Mitotane
sc-484500Mitotane-d4
A10594-250Mitotane 250mg
A10594-1000Mitotane 1000mg
A8475-100Mitotane (Lsodren)

Popular Products